Myeloma is a relatively rare cancer that strikes an estimated 26,000 Americans each year. If you've been diagnosed with myeloma, talk to us. It's important to learn about your options as soon as you can. Our world-class team of myeloma specialists can answer your questions, address your concerns, and deliver a personalized treatment plan with the most innovative, cutting-edge therapies available anywhere.
At City of Hope's Judy and Bernard Briskin Center for Multiple Myeloma Research, we are committed to treating the whole person, body and soul. We have an unmatched reputation for coordinated, compassionate care. We bring together a broad array of myeloma expertise from multiple disciplines, all under one roof:
Plus, your care continues long after treatment is complete, with our unique family and survivorship programs.
City of Hope is the only southern California member of the Multiple Myeloma Research Consortium, dedicated to rapidly bringing the most promising treatments to patients. We are recognized internationally for our research and breakthrough treatments. We operate one of the largest transplant centers in the U.S., producing some of the consistently best outcomes. We are designated a Comprehensive Cancer Center by the National Cancer Institute, and for over a decade, U.S. News & World Report has named City of Hope one of the top cancer hospitals in America.
If you have been diagnosed with myeloma or multiple myeloma or are looking for a second opinion consultation about your treatment, request an appointment online or contact us at 800-826-HOPE. Please visit Making Your First Appointment for more information.
City of Hope’s renowned physicians and researchers utilize the latest in technology and innovation to treat cancer, coupled with our enduring belief in providing unparalleled compassionate care.
Anatomic and Clinical Pathology
At City of Hope, we were among the first to build and develop a Bone Marrow and Stem Cell Transplant program which has performed more than 12,000 procedures since 1976. City of Hope has been recognized for superior survival outcomes for 10 consecutive years—the only transplant center in the United States with such an achievement.
Beyond transplants, we also offer the broadest range of myeloma treatments available, including adoptive T-cell therapy, helical TomoTherapy and monoclonal antibody therapy.
Every patient is different, with different needs. At City of Hope, we treat you as a valued individual. Our entire team works together to bring you precise, state-of-the-art chemotherapy, immunotherapy, radiation and transplant options that will deliver the best outcome for you. We support you every step of the way, both during treatment and long after, helping you and your loved ones manage your recovery.
City of Hope is a recognized leader in myeloma research. We are determined to leverage world-class research into leading-edge therapies and make them available to patients as rapidly as possible. Clinical trials play a vital role in this work.
The Kenneth Goldman and Julie Harelson Clinical Trials Program manages and coordinates all trials related to the treatment of multiple myeloma. We offer access to dozens of clinical trials and new therapies not always available elsewhere.
Our latest research is focused on new drugs and drug combinations that target and attack relapsed myeloma which has become resistant to first-line treatment.
Browse through some of our clinical trials and research projects here.
Join a community of people who understand what you’re going through…
The Leukemia & Lymphoma Society’s Community is an online community of people living with or supporting someone with blood cancer. Get connected and share your voice to drive change.
City of Hope experts cover prevention, screening, treatment and other cancer topics on City of Hope’s Breakthrough’s blog.